Zymeworks (ZYME) Current Deferred Revenue (2021 - 2023)

Historic Current Deferred Revenue for Zymeworks (ZYME) over the last 3 years, with Q3 2023 value amounting to $93000.0.

  • Zymeworks' Current Deferred Revenue fell 9971.77% to $93000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $93000.0, marking a year-over-year decrease of 9971.77%. This contributed to the annual value of $32.9 million for FY2022, which is 0.0% changed from last year.
  • Zymeworks' Current Deferred Revenue amounted to $93000.0 in Q3 2023, which was down 9971.77% from $17.8 million recorded in Q2 2023.
  • Zymeworks' 5-year Current Deferred Revenue high stood at $32.9 million for Q4 2021, and its period low was $93000.0 during Q3 2023.
  • In the last 3 years, Zymeworks' Current Deferred Revenue had a median value of $25.4 million in 2021 and averaged $19.8 million.
  • Per our database at Business Quant, Zymeworks' Current Deferred Revenue changed by 0.0% in 2022 and then tumbled by 9971.77% in 2023.
  • Quarter analysis of 3 years shows Zymeworks' Current Deferred Revenue stood at $32.9 million in 2021, then changed by 0.0% to $32.9 million in 2022, then tumbled by 99.72% to $93000.0 in 2023.
  • Its last three reported values are $93000.0 in Q3 2023, $17.8 million for Q2 2023, and $2.4 million during Q1 2023.